Novo Nordisk CEO says job cuts affecting 9,000 staff almost complete

COPENHAGEN (Reuters) -Novo Nordisk has notified employees impacted by the drugmaker's job cuts in the vast majority of its locations although the pace varies according to local laws, its CEO Mike Doustdar wrote in a post on LinkedIn on Friday.

Doustdar launched a restructuring drive last month, including 9,000 job cuts globally as Novo faces heated competition in the United States, the world's biggest drug market, against rival Eli Lilly.

(Reporting by Stine Jacobsen, writing by Louise Breusch Rasmussen, editing by)

You May Also Be Interested In

• Uber stock gains 2% as tech giant cuts 3,300 jobs in major restructuring
• Explainer-Why is Senegal reworking its debt and what makes it different?
• Fed survey shows economic activity edged up, prices rose moderately in recent weeks